The Role of Prophylactic Heart Failure Therapy in Duchenne Muscular Dystrophy

There is variable practice and debate surrounding prophylactic heart failure (HF) therapy in Duchenne Muscular Dystrophy (DMD) patients with normal systolic function. We sought to determine the impact of HF medications including ACE inhibitors and ARB on the development of moderate systolic dysfunction or death in a cohort of DMD patients.

Source: The Journal of Heart and Lung Transplantation - March 16, 2019 Category: Transplant Surgery Authors: A.K. Lal, C.A. Wittlieb-Weber, C.R. Villa, J. Conway, M.J. Bock, K.E. Gambetta, K.R. Schumacher, S.P. Law, S.R. Deshpande, S.C. West, J.M. Friedland-Little, I.D. Lytrivi, M.A. McCulloch, R.J. Butts, K.R. Knecht, Z. Ou, A.P. Presson, J.N. Johnson Tags: 1177 Source Type: research